QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

Background: Observational studies have suggested increased arrhythmic and cardiovascular risk with the combination use of hydroxychloroquine (HCQ) and azithromycin in patients with coronavirus disease 2019 (COVID-19). Objective: The arrhythmic safety profile of HCQ monotherapy, which remains under i...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Arun R. Sridhar, MBBS, MPH, Neal A. Chatterjee, MD, MSc, Basil Saour, MD, Dan Nguyen, MD, Elizabeth A. Starnes, ARNP, Christine Johnston, MD, MPH, Margaret L. Green, MD, MPH, Gregory A. Roth, MD, Jeanne E. Poole, MD, FHRS
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Elsevier 2020-08-01
Ráidu:Heart Rhythm O2
Fáttát:
Coronavirus
Electrocardiogram
Hydroxychloroquine
QT interval
Ventricular arrhythmia
Liŋkkat:http://www.sciencedirect.com/science/article/pii/S2666501820300751

Interneahtta

http://www.sciencedirect.com/science/article/pii/S2666501820300751

Geahča maid